Date:October 28, 2012

Richard Hurwitz, MD

Richard Hurwitz, M.D.Associate Professor
Department of Pediatrics
Section of Hematology-Oncology, and
Department of Ophthalmology, and
Department of Molecular & Cellular Biology
Baylor College of Medicine

Director, Retinoblastoma Center
Texas Children’s Cancer Center

Dr. Richard Hurwitz
Texas Children’s Cancer Center
1102 Bates Street, Suite 1025.24
Houston, TX 77030

Phone: 832-824-4259
Fax: 832-825-4846


Dr. Richard Hurwitz studies the potential use of gene therapy for the treatment of ocular diseases. He has shown that a novel treatment for retinoblastoma using suicide gene therapy is safe and possibly effective in children. To further refine this therapeutic option, Dr. Hurwitz is studying the cellular origin of retinoblastoma and the differences between invasive and non-invasive forms of this disease. In addition, in vivo models of retinitis pigmentosa and macular degeneration are being used to develop gene therapy treatments for retinal degenerative diseases. The mechanism of adenoviral-mediated transgene expression in the ocular environment is being explored with goals of providing future molecular targets to modulate adenoviral-mediated gene therapy for both retinoblastoma and retinal degenerative diseases and possibly of controlling adenovirus infection in general.

Dr. Richard Hurwitz is a Co-Director of the Retinoblastoma Center.


M.D., Albany Medical College
Internship and Fellowship, University of Minnesota Hospitals
Fellowship, University of Washington

Board Certifications

American Board of Pediatrics
American Board of Pediatrics-Hematology/Oncology

Selected Memberships

Member, American Society of Biochemistry and Molecular Biology
Member, The Society for Pediatric Research
Member, Association for Research in Vision & Ophthalmology
Member, American Academy of Pediatrics
Member, American Association for Cancer Research
Member, Harris County Medical Society
Member, Texas Medical Association
Member, Texas Pediatric Society
Member, International Society for Ocular Oncology
Member, International Society for Genetic Eye Diseases and Retinoblastoma

Clinical Interests

Gene Therapy

Research Interests

Gene therapy for ocular diseases.
Cellular origin of retinoblastoma
Retinal degenerative diseases

Learn about the Research Laboratory of Richard Hurwitz